Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical…
News
Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering
Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
OKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares
LONDON and NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO)…
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC…
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies…
As Hurricane Lee looms in the Atlantic, Verizon is ready
AUGUSTA, Maine, Sept. 14, 2023 (GLOBE NEWSWIRE) — With Lee lurking in the Atlantic, Verizon’s…
Pax8 Expands Vendor Portfolio with Private Offer Vendors
Enabling Partners to Sell Third-Party Solutions DENVER, Sept. 14, 2023 (GLOBE NEWSWIRE) — Pax8, the…
Virtual reality simulation ensures job seekers and employers succeed together
EDMONTON, Alberta, Sept. 14, 2023 (GLOBE NEWSWIRE) — A new program delivered through virtual reality…
Evergent Revenue and Royalty Management (ERRM) Now Available in AWS Marketplace
AWS Marketplace Listing Expands Reach of Evergent’s SaaS Solution to AWS Customers and AWS Partners,…
Personas Provides Update on Keek Marketing Launch
Toronto, Ontario–(Newsfile Corp. – September 14, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“)…
OutSystems ONE Conference Celebrates Developer Community Growth and More Than 100K New Community Members
Conference gathers 1,600 global developers to advance high-performance low-code education, innovation, and career growth LISBON,…
KBRA Assigns Preliminary Ratings to OBX 2023-NQM7 Trust (OBX 2023-NQM7)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from OBX 2023-NQM7…
KBRA Assigns Preliminary Ratings to GCAT 2023-NQM3 Trust
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage pass-through notes from GCAT…
Atmosic and Nichicon Announce Energy Harvesting Solution to Reduce Battery Waste in the IoT
New solution will help brands design more sustainable wearable and IoT Bluetooth applications in small…
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to…
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to…
Scilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate to Severe Acute Lower Back Pain (LBP)
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety…
Scilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate to Severe Acute Lower Back Pain (LBP)
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety…
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) — Fresh data from randomized controlled NASAR…
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) — Fresh data from randomized controlled NASAR…